List date(s) this work was published or aired.
Nov. 9, 2012
Provide a brief synopsis of the story or stories, including any significant findings.
New tests have discovered compounds for extending the treatment window for stroke patients.
Explain types of documents, data or Internet resources used. Were FOI or public records act requests required? How did this affect the work?
1. Scientific presentation by Jennifer Iaci on Feb. 2, 2012, at the American Heart Association/American Stroke Association International Stroke Conference, entitled “Dalfampridine Improves Sensorimotor Function in Rats with Chronic Deficits Following Middle Cerebral Artery Occlusion.” 2. Article in Nature Medicine on June 22, 2008, by Dr. Daniel Lawrence, et al.
Explain types of human sources used.
Biomedical scientists were consulted on the scientific data explained in the article, specifically how these compounds work during a stroke.
Results:
We received positive repsonses from victims of strokes and their loved ones.
Follow-up (if any). Have you run a correction or clarification on the report or has anyone come forward to challenge its accuracy? If so, please explain.
No. One of the studies referenced is ongoing, but so far none of the data contradicts what we wrote.
Advice to other journalists planning a similar story or project.
Highlight the benefit to patients and their caregivers. Also, remind the audience that strokes don’t just strike those who are elderly.